An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile

dc.contributor.affiliationDepartamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
dc.contributor.affiliationCentro de Biotecnología Acuícola, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile
dc.contributor.affiliationEscuela de Medicina, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile
dc.contributor.affiliationCentro de Investigaciones Biomédicas y Aplicadas, Escuela de Medicina, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile
dc.contributor.affiliationCentro de Nanociencia y Nanotecnología CEDENNA, Universidad de Santiago de Chile, Santiago, Chile
dc.contributor.affiliationNúcleo de Investigaciones Aplicadas en Ciencias Veterinarias y Agronómicas, Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago, La Florida, Chile
dc.contributor.authorAcuña-Castillo, Claudio
dc.contributor.authorBarrera-Avalos, Carlos
dc.contributor.authorBachelet, Vivienne C.
dc.contributor.authorMilla, Luis A.
dc.contributor.authorInostroza-Molina, Ailén
dc.contributor.authorVidal, Mabel
dc.contributor.authorLuraschi, Roberto
dc.contributor.authorVallejos-Vidal, Eva
dc.contributor.authorMella-Torres, Andrea
dc.contributor.authorValdés, Daniel
dc.contributor.authorReyes-López, Felipe E.
dc.contributor.authorImarai, Mónica
dc.contributor.authorRojas, Patricio
dc.contributor.authorSandino, Ana María
dc.date.accessioned2024-09-03T19:19:08Z
dc.date.available2024-09-03T19:19:08Z
dc.date.issued2023-07-10
dc.description.abstractIntroduction As the SARS-CoV-2 continues to evolve, new variants pose a significant threat by potentially overriding the immunity conferred by vaccination and natural infection. This scenario can lead to an upswing in reinfections, amplified baseline epidemic activity, and localized outbreaks. In various global regions, estimates of breakthrough cases associated with the currently circulating viral variants, such as Omicron, have been reported. Nonetheless, specific data on the reinfection rate in Chile still needs to be included. Methods Our study has focused on estimating COVID-19 reinfections per wave based on a sample of 578,670 RT-qPCR tests conducted at the University of Santiago of Chile (USACH) from April 2020 to July 2022, encompassing 345,997 individuals. Results The analysis reveals that the highest rate of reinfections transpired during the fourth and fifth COVID-19 waves, primarily driven by the Omicron variant. These findings hold despite 80% of the Chilean population receiving complete vaccination under the primary scheme and 60% receiving at least one booster dose. On average, the interval between initial infection and reinfection was found to be 372 days. Interestingly, reinfection incidence was higher in women aged between 30 and 55. Additionally, the viral load during the second infection episode was lower, likely attributed to Chile's high vaccination rate. Discussion This study demonstrates that the Omicron variant is behind Chile's highest number of reinfection cases, underscoring its potential for immune evasion. This vital epidemiological information contributes to developing and implementing effective public health policies.
dc.description.sponsorshipFunding text 1: The Laboratory of Virology had support from the COVID-19 diagnosis in the University laboratories network (Ministry of Sciences, Ministry of Health, and Government of Chile) for diagnosis tasks. The authors are also grateful for the rapid assignment of resources for research projects on the Coronavirus pandemic (COVID-19) [project number COVID1038; Agencia Nacional de Investigación y Desarrollo de Chile (ANID), Government of Chile], Fondecyt regular project numbers 1201664 (MI), 1211841 (FER-L), and 1231554 (CA-C), and Fondecyt iniciación No. 11221308 (EV-V) and No. 11231081 (CB-A). The authors are also grateful to the DICYT-USACH project number 021943AC (CA-C), DICYT-USACH 082344RL_Postdoc (FER-L), 082344RL_Ayudante (FER-L), and DICYT 022343RM (PR). The funders had no role in study design, data collection and analysis, and the decision to publish, or the preparation of the manuscript.; Funding text 2: The Laboratory of Virology had support from the COVID-19 diagnosis in the University laboratories network (Ministry of Sciences, Ministry of Health, and Government of Chile) for diagnosis tasks. The authors are also grateful for the rapid assignment of resources for research projects on the Coronavirus pandemic (COVID-19) [project number COVID1038; Agencia Nacional de Investigación y Desarrollo de Chile (ANID), Government of Chile], Fondecyt regular project numbers 1201664 (MI), 1211841 (FER-L), and 1231554 (CA-C), and Fondecyt iniciación No. 11221308 (EV-V) and No. 11231081 (CB-A). The authors are also grateful to the DICYT-USACH project number 021943AC (CA-C), DICYT-USACH 082344RL_Postdoc (FER-L), 082344RL_Ayudante (FER-L), and DICYT 022343RM (PR). The funders had no role in study design, data collection and analysis, and the decision to publish, or the preparation of the manuscript.
dc.format.mimetypeapplication/pdf
dc.identifier.citationFrontiers in Public Health, 11, 1191377. https://doi.org/10.3389/fpubh.2023.1191377
dc.identifier.doihttps://doi.org/10.3389/fpubh.2023.1191377
dc.identifier.folio11221308
dc.identifier.folio11231081
dc.identifier.folio1201664
dc.identifier.folio1211841
dc.identifier.folio1231554
dc.identifier.issn2296-2565
dc.identifier.orcidhttps://orcid.org/0000-0003-3607-6077
dc.identifier.orcidhttps://orcid.org/0000-0001-6160-9563
dc.identifier.orcidhttps://orcid.org/0000-0002-5715-9755
dc.identifier.orcidhttps://orcid.org/0000-0001-9738-6234
dc.identifier.orcidhttps://orcid.org/0000-0002-0800-1353
dc.identifier.orcidhttps://orcid.org/0000-0001-5611-4320
dc.identifier.orcidhttps://orcid.org/0000-0002-3091-2700
dc.identifier.orcidhttps://orcid.org/0000-0002-7207-619X
dc.identifier.orcidhttps://orcid.org/0000-0002-5001-457X
dc.identifier.orcidhttps://orcid.org/0000-0001-8767-9180
dc.identifier.orcidhttps://orcid.org/0000-0002-3862-3743
dc.identifier.pmid37492136
dc.identifier.rorhttps://ror.org/02ma57s91
dc.identifier.rorhttps://ror.org/0166e9x11
dc.identifier.scopusauthorid6603281718
dc.identifier.scopusauthorid57195985435
dc.identifier.scopusauthorid56815126400
dc.identifier.scopusauthorid10040983600
dc.identifier.scopusauthorid57232069400
dc.identifier.scopusauthorid57223819306
dc.identifier.scopusauthorid55854290500
dc.identifier.scopusauthorid46061320500
dc.identifier.scopusauthorid57217385219
dc.identifier.scopusauthorid6602680747
dc.identifier.scopusauthorid36773500800
dc.identifier.scopusauthorid57190291825
dc.identifier.scopusauthorid7005445744
dc.identifier.scopusauthorid6603906080
dc.identifier.urihttps://repositorio.udla.cl/handle/udla/1416
dc.language.isoeng
dc.publisherFrontiers Media SA
dc.relation.fundingDICYT 022343RM
dc.relation.fundingMinistry of Health, MOH, (COVID1038)
dc.relation.fundingMinistry of Health, MOH
dc.relation.fundingFondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT, (11221308, 11231081, 1201664, 1211841, 1231554)
dc.relation.fundingFondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT
dc.relation.fundingAgencia Nacional de Investigación y Desarrollo, ANID
dc.relation.isindexedbyScopus
dc.relation.issn2296-2565
dc.rightsCreative Commons Attribution 4.0 International
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceFrontiers in Public Health
dc.source.urihttps://doi.org/10.3389/fpubh.2023.1191377
dc.subjectCOVID-19 pandemic
dc.subjectreinfection
dc.subjectSARS-CoV-2
dc.subjectvaccines
dc.subjectvariants of concern
dc.subject.lcshCOVID-19 pandemia, 2020-
dc.subject.lcshVacunas
dc.titleAn ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile
dc.title.alternativeAn ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile.
dc.typejournal article
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.udla.catalogadorCBM
oaire.citation.titleFrontiers in Public Health
oaire.citation.volume11
oaire.fundingReference.awardNumber11221308
oaire.fundingReference.awardNumber11231081
oaire.fundingReference.awardNumber1201664
oaire.fundingReference.awardNumber1211841
oaire.fundingReference.awardNumber1231554
oaire.fundingReference.funderNameAgencia Nacional de Investigación y Desarrollo (ANID)
udla.curacion.controljmvg
udla.odsODS 3: Salud y bienestar
udla.oecd.area1 Ciencias Naturales
udla.oecd.discipline1.6.3 Virología
udla.oecd.subarea1.6 Ciencias Biológicas

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
341.pdf
Size:
2.92 MB
Format:
Adobe Portable Document Format

Collections